Pharmacometrics Markup Language (PharmML): Opening new perspectives for model exchange in drug development

CPT: Pharmacometrics and Systems Pharmacology

Volumn 4, Issue 6, 2015, Pages 316-319

  Swat, M J ^a   Moodie, S ^b   Wimalaratne, S M ^a   Kristensen, N R ^c   Lavielle, M ^d   Mari, A ^e   Magni, P ^f   Smith, M K ^g   Bizzotto, R ^h,x   Pasotti, L ^f   Mezzalana, E ^f   Comets, E ^h,x   Sarr, C ⁱ   Terranova, N ^j   Blaudez, E ^k   Chan, P ^g   Chard, J ^l   Chatel, K ^k   Chenel, M ^m,y   Edwards, D ⁿ   Franklin, C ^o   Giorgino, T ^e   Glont, M ^a   Girard, P ^j   Grenon, P ^p   Harling, K ^q   Hooker, A C ^q   Kaye, R ^l   Keizer, R ^q   Kloft, C ^r   Kok, J N ^s   Kokash, N ^s   Laibe, C ^a   Laveille, C ^m,y   Lestini, G ^h,x   Mentre F ^h,x   Munafo, A ^j   Nordgren, R ^q   Nyberg, H B ^l,q   Parra Guillen, Z P ^r   Plan, E ^q   Ribba, B ^t   Smith, G ^u   Troconiz I F ^v   Yvon, F ^a   Milligan, P A ^g   Harnisch, L ^g   Karlsson, M ^q   Hermjakob, H ^a   Le Novere N ^a,w   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b Eight Pillars Ltd   (United Kingdom)

^c NOVO NORDISK A S   (Denmark)

^d INRIA SACLAY   (France)

^e CNR   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

^g PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^h UNIVERSITÉ PARIS DIDEROT   (France)

ⁱ NOVARTIS PHARMA AG   (Switzerland)

^j Merck Institute for Pharmacometrics Merck Serono   (Switzerland)

^k Lixoft   (France)

^l Mango Solutions   (United Kingdom)

^m Exprimo NV   (Belgium)

ⁿ CERTARA UK LIMITED   (United Kingdom)

^o CPMS Technology and Development   (United Kingdom)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

^q UPPSALA UNIVERSITY   (Sweden)

^r FREIE UNIVERSITÄT BERLIN   (Germany)

^s LEIDEN UNIVERSITY   (Netherlands)

^t INRIA RHÔNE ALPES   (France)

^u CYPROTEX DISCOVERY LTD   (United Kingdom)

^v UNIVERSITY OF NAVARRA   (Spain)

^w BABRAHAM INSTITUTE   (United Kingdom)

^x UNIVERSITÉ PARIS DESCARTES   (France)

^y IRIS Institut de Recherches Internationales Servier   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); COMPUTER PROGRAM; COMPUTER SIMULATION; DRUG DESIGN; EXPERIMENTAL DESIGN; INTERNET; MACHINE LEARNING; MARKUP LANGUAGE; MATHEMATICAL MODEL; MOTIVATION; PHARMACOLOGICAL PARAMETERS; PHARMACOLOGICAL PROCEDURES; PHARMACOMETRICS MARKUP LANGUAGE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; STUDY DESIGN; SYSTEMS BIOLOGY; WORKFLOW;

EID: 84936749645     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1002/psp4.57     Document Type: Review

References (10)

1. Mould, D.R., &, Upton, R.N., Basic concepts in population modeling, simulation, and model-based drug development. CPT Pharmacometrics Syst. Pharmacol. 1, e6 (2012).
2. Harnisch, L., Matthews, I., Chard, J., &, Karlsson, M.O., Drug and disease model resources: a consortium to create standards and tools to enhance model-based drug development. CPT Pharmacometrics Syst. Pharmacol. 2, e34 (2013).
3. Sauro, H.M., &, Bergmann F., Standards and ontologies in computational systems biology. Essays Biochem. 45, 211-222 (2008).
4. Beal, S.L., Sheiner, L.B., Boeckmann, A.J., &, Bauer, R.J., NONMEM User's Guides. Technical report, Icon Development Solutions, Ellicott City, MD, USA (2009).
5. Lixoft, Monolix 4.3. < http://lixoft.com >.
6. Li, C., et al,. BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst. Biol. 4, 92 (2010).
7. Lavielle, M., Mixed Effects Models for the Population Approach Models, Tasks, Methods & Tools (Chapman & Hall/CRC Biostatistics Series 2014).
8. Bonate, P., Pharmacokinetic-Pharmacodynamic Modeling and Simulation 2nd ed. (Springer, 2011).
9. CDISC SDM-XML Technical Committee. CDISC Study Design Model in XML (SDM-XML), Version 1.0. Technical report, Clinical Data Interchange Standards Consortium. < www.cdisc.org > (2011).
10. Hucka, M., et al,. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19, 524-531 (2003).